G.K.H. Au

782 total citations
22 papers, 581 citations indexed

About

G.K.H. Au is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, G.K.H. Au has authored 22 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Otorhinolaryngology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in G.K.H. Au's work include Head and Neck Cancer Studies (10 papers), Cancer Treatment and Pharmacology (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). G.K.H. Au is often cited by papers focused on Head and Neck Cancer Studies (10 papers), Cancer Treatment and Pharmacology (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). G.K.H. Au collaborates with scholars based in China, Hong Kong and United States. G.K.H. Au's co-authors include Jonathan S. T. Sham, WI Wei, To‐Wai Leung, Brian O’Sullivan, Wai Tong Ng, W.H. Lau, Dtt Chua, Dora L.�W. Kwong, L.L. Siu and Shui‐Yi Tung and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

G.K.H. Au

21 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.K.H. Au China 11 308 293 225 167 73 22 581
Merril Kies United States 10 320 1.0× 248 0.8× 295 1.3× 271 1.6× 10 0.1× 10 607
A. Caldara Italy 9 70 0.2× 172 0.6× 71 0.3× 124 0.7× 3 0.0× 26 309
Ana Castro Portugal 8 342 1.1× 239 0.8× 199 0.9× 220 1.3× 2 0.0× 13 577
Fatma Paksoy Türköz Türkiye 10 36 0.1× 284 1.0× 64 0.3× 137 0.8× 37 0.5× 19 467
Pierre Boisselier France 11 173 0.6× 96 0.3× 112 0.5× 257 1.5× 4 0.1× 22 520
Tobias Bartscht Germany 11 32 0.1× 203 0.7× 174 0.8× 174 1.0× 10 0.1× 63 465
Anne-Birgitte Jacobsen Norway 13 46 0.1× 184 0.6× 196 0.9× 141 0.8× 5 0.1× 30 452
Beatriz Cirauqui Spain 13 101 0.3× 357 1.2× 71 0.3× 197 1.2× 3 0.0× 56 549
Patrick Cavanaugh United States 9 35 0.1× 252 0.9× 149 0.7× 163 1.0× 17 0.2× 16 556
Miho Kawashima Japan 9 18 0.1× 54 0.2× 37 0.2× 113 0.7× 15 0.2× 33 293

Countries citing papers authored by G.K.H. Au

Since Specialization
Citations

This map shows the geographic impact of G.K.H. Au's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.K.H. Au with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.K.H. Au more than expected).

Fields of papers citing papers by G.K.H. Au

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.K.H. Au. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.K.H. Au. The network helps show where G.K.H. Au may publish in the future.

Co-authorship network of co-authors of G.K.H. Au

This figure shows the co-authorship network connecting the top 25 collaborators of G.K.H. Au. A scholar is included among the top collaborators of G.K.H. Au based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.K.H. Au. G.K.H. Au is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tung, Shui‐Yi, Dtt Chua, Roger K.C. Ngan, et al.. (2010). Randomized Trial of Radiotherapy Plus Concurrent-Adjuvant Chemotherapy vs Radiotherapy Alone for Regionally Advanced Nasopharyngeal Carcinoma. JNCI Journal of the National Cancer Institute. 102(15). 1188–1198. 240 indexed citations
2.
3.
Au, G.K.H., et al.. (2009). Triple Negative Breast Cancer Patients with Brain Metastasis Are Associated with More Concurrent Lung Metastases.. Cancer Research. 69(24_Supplement). 3072–3072. 1 indexed citations
4.
Wei, WI, et al.. (2008). Capecitabine Monotherapy for Recurrent and Metastatic Nasopharyngeal Cancer. Japanese Journal of Clinical Oncology. 38(4). 244–249. 52 indexed citations
5.
Chan, Kelvin Y.K., Jirong Long, Shea Ping Yip, et al.. (2008). Functional polymorphisms in the BRCA1 promoter influence transcription and are associated with decreased risk for breast cancer in Chinese women. Journal of Medical Genetics. 46(1). 32–39. 18 indexed citations
6.
Kwong, Dora L.�W., et al.. (2008). Long-term results of concurrent and adjuvant chemotherapy for advanced nasopharyngeal carcinoma. Journal of Clinical Oncology. 26(15_suppl). 6056–6056. 1 indexed citations
7.
Choi, Chang‐In, Stewart Y. Tung, Louis Tak Lui, et al.. (2007). Efficacy of Combination Chemotherapy with Irinotecan (CPT-11) plus Capecitabine in Patients with Metastatic or Advanced Colorectal Carcinoma — a Dual-centre Phase II Study: the MAC-6. Clinical Oncology. 20(2). 168–175. 7 indexed citations
8.
Chua, Daniel T. T., Jonathan S. T. Sham, & G.K.H. Au. (2007). A phase II trial of gefitinib in recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy. Journal of Clinical Oncology. 25(18_suppl). 6042–6042. 3 indexed citations
9.
Sham, Jst, et al.. (2006). 27. International Journal of Radiation Oncology*Biology*Physics. 66(3). S15–S16. 5 indexed citations
10.
Au, G.K.H., et al.. (2005). Hypersensitivity reactions to oxaliplatin: experience in a single institute. Annals of Oncology. 17(2). 259–261. 92 indexed citations
11.
Chua, Daniel T. T., Jonathan S. T. Sham, & G.K.H. Au. (2005). Induction chemotherapy with cisplatin and gemcitabine followed by re-irradiation for locally recurrent nasopharyngeal carcinoma. Journal of Clinical Oncology. 23(16_suppl). 5535–5535.
12.
Pow, Ehn, et al.. (2003). Intensity-modulated radiotherapy for early stage nasopharyngeal carcinoma: preliminary results on parotid sparing. International Journal of Radiation Oncology*Biology*Physics. 57(2). S303–S303. 4 indexed citations
13.
Au, G.K.H., et al.. (2001). Radiation Recall with Oxaliplatin: Report of a Case and a Review of the Literture. Clinical Oncology. 13(1). 55–57. 14 indexed citations
14.
Au, G.K.H., et al.. (2001). Radiation Recall with Oxaliplatin: Report of a Case and a Review of the Literture. Clinical Oncology. 13(1). 55–57. 2 indexed citations
15.
Ooi, G.C., Jcm Ho, Franky Leung Chan, et al.. (2001). Pulmonary sequelae of treatment for breast cancer: a prospective study. International Journal of Radiation Oncology*Biology*Physics. 50(2). 411–419. 32 indexed citations
16.
Chua, Daniel T. T., Dora L.�W. Kwong, Jonathan S. T. Sham, G.K.H. Au, & D. Choy. (2000). A phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy. European Journal of Cancer. 36(6). 736–741. 33 indexed citations
17.
Ooi, G.C., Dora L.�W. Kwong, K N Chan, et al.. (2000). Serial HRCT Lung Changes after 3-Field Radiation Treatment of Breast Cancer. Clinical Radiology. 55(11). 817–824. 16 indexed citations
18.
Chow, Louis W.C., et al.. (1997). Current status of breast cancer in Hong Kong.. PubMed. 110(6). 474–8. 24 indexed citations
20.
Chowdhury, Chitta Ranjan, et al.. (1988). Prospective Study of the Effects of Ventilation Tubes on Hearing after Radiotherapy for Carcinoma of Nasopharynx. Annals of Otology Rhinology & Laryngology. 97(2). 142–145. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026